IRM
41
10
LYB
22
2
MPC
38
2
TEL
66
6
WDC
70
2
CAH
63
3
KIM
50
-3
JPM
70
3
BEN
55
2
CL
58
2
CMI
71
2
ALLE
44
3
HD
28
-4
M
58
5
TAP
29
-11
CTAS
40
-2
FFIV
47
-3
QCOM
45
2
CMCSA
44
-2
PLD
30
2
IRM
41
10
LYB
22
2
MPC
38
2
TEL
66
6
WDC
70
2
CAH
63
3
KIM
50
-3
JPM
70
3
BEN
55
2
CL
58
2
CMI
71
2
ALLE
44
3
HD
28
-4
M
58
5
TAP
29
-11
CTAS
40
-2
FFIV
47
-3
QCOM
45
2
CMCSA
44
-2
PLD
30
2
Financhill
Back

Aspen Pharmacare Holdings Ltd. 10K Form

Buy
56

APNHY
Aspen Pharmacare Holdings Ltd.

Last Price:
$5.68
Seasonality Move:
6.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive APNHY News And Ratings

See the #1 stock for the next 7 days that we like better than APNHY

APNHY Financial Statistics

Sales & Book Value

Annual Sales: $2.4B
Cash Flow: $0
Price / Cash Flow: 445.95
Annual Sales: $10.19
Price / Book: 0.62

Profitability

EPS (TTM): -0.12540
Net Income (TTM): $-55.7M
Gross Margin: $1B
Return on Equity: 5.41%
Return on Assets: 3.33%

Aspen Pharmacare Holdings Ltd. Earnings Forecast

Key Aspen Pharmacare Holdings Ltd. Financial Ratios

  • The Gross Profit Margin over the past 29 years for APNHY is 42.02%.
  • The Selling, General & Administrative Expenses for APNHY have been equal to 25.35% of Gross Profit Margin.
  • The Research & Development expenses have been 0.01% of Revenue.
  • The Net Earning history of APNHY is -2.50% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 16 years.

Aspen Pharmacare Holdings Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: APNHY
Website: aspenpharma.com

Debt

Debt-to-Equity Ratio: 0.42
Current Ratio: 2.35
Quick Ratio: 1.25

Price-to-Earnings

Trailing P/E Ratio: 11.17
Forward P/E Ratio: 0

APNHY Technical Analysis vs Fundamental Analysis

Buy
56
Aspen Pharmacare Holdings Ltd. (APNHY) is a Buy

Is Aspen Pharmacare Holdings Ltd. a Buy or a Sell?